RNAi Technology Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Global RNAi Companies & Analysis and it is Segmented by Application (Drug Discovery and Development, Therapeutics [Oncology, Ocular Disorders, Respiratory Disorders, Hepatitis B and C, Autoimmune Hepatitis, Neurological Disorders, and Other Therapeutics]) and Geography (North America, Europe, Asia-Pacific, and Rest of the World). The market provides the value (in USD million) for the above segments.

RNAi Technology Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

RNAi Technology Industry Overview

The RNA-interference (RNAi) market is highly competitive and consists of a few major players. Companies like Alnylam Pharmaceuticals, Arrowhead, Dicerna Pharmaceuticals (Novo Nordisk A/S), Thermofisher Scientific, Silence Therapeutics PLC, among others, hold a substantial market share in the RNA-interference (RNAi) market.

RNAi Technology Market Leaders

  1. Alnylam Pharmaceuticals

  2. Silence Therapeutics PLC

  3. Arrowhead Pharmaceuticals, Inc.

  4. Thermo Fisher Scientific Inc

  5. Dicerna Pharmaceuticals (Novo Nordisk A/S)

  6. *Disclaimer: Major Players sorted in no particular order
Picture1.png

RNAi Technology Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?